Express News | AstraZeneca Reports FDA Approved Durvalumab With Chemotherapy For Mismatch Repair Deficient Primary Advanced Or Recurrent Endometrial Cancer
Express News | FDA Says On June 13 Updates Advice To Manufacturers Of Covid-19 Vaccines (2024-2025 Formula): If Feasible Use KP.2 Strain Of JN.1-Lineage
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading
European equities traded in the US as American depositary receipts were trending sharply lower Friday, falling 1.3% to 1,404.81 on the S&P Europe Select ADR Index, which is set to end the week down 1.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
AstraZeneca CFO: 'We've Come a Long Way in Our Oncology Portfolio'
Express News | Insmed Shares Are Trading Higher After Announcing That No Agreement Was Reached Between the Company and AstraZeneca and Insmed Retains Full Worldwide Development and Commercialization Rights for Brensocatib in All Indications Other Than COPD or Asthma...
FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
AstraZeneca's Type-2 Diabetes Drug Wins Pediatric Approval in US
AstraZeneca (AZN.L, AZN.ST) received approval from the US Food and Drug Administration for its Farxiga treatment for pediatric type-2 diabetes for children aged 10 years or older. The healthcare giant
FARXIGA Approved in the US for the Treatment of Pediatric Type-2 Diabetes
AstraZeneca's FARXIGA (dapagliflozin) has been approved by the US Food and Drug Administration (FDA) to improve glycemic control in pediatric patients with type-2 diabetes (T2D) aged 10 years and older.
Express News | AstraZeneca Says Farxiga Has Been Approved By FDA To Improve Glycaemic Control In Paediatric Patients With Type-2 Diabetes Aged 10 Years And Older
Express News | AstraZeneca Says Farxiga Approved In U.S. For Treatment Of Paediatric Type-2 Diabetes
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
AstraZeneca Champions Early Kidney Disease Diagnosis With Modelling Data
Why AstraZeneca Plc (NASDAQ:AZN) Is Investors' One of Favorite International Dividend Stock?
Astrazeneca (AZN) Advances But Underperforms Market: Key Facts
AstraZeneca's (AZN) Tagrisso SNDA Gets FDA's Priority Tag
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
Centessa Pharma Hires CFO From Fusion After AstraZeneca Takeover
By Dean Seal Centessa Pharmaceuticals has hired the former chief financial officer of Fusion Pharmaceuticals after the latter company was acquired by AstraZeneca. The clinical-stage pharmaceutical c
Berenberg Raises Price Target on AstraZeneca to GBP150 From GBP130, Cites More Confidence in Longer-Term Outlook, Keeps Buy Rating
Berenberg Raises Price Target on AstraZeneca to GBP150 From GBP130, Cites More Confidence in Longer-Term Outlook, Keeps Buy Rating.
AstrraZeneca Announced Earlier Tagrisso Granted Priority Review In The US For Patients With Unresectable, Stage III EGFR-mutated Lung Cancer
AstraZeneca's supplemental New Drug Application (sNDA) for Tagrisso (osimertinib) has been accepted and granted Priority Review in the US for the treatment of adult patients with unresectable, Stage I
No Data